Bim suppresses the development of SLE by limiting myeloid inflammatory responses
Journal Title
J Exp Med
Publication Type
Journal Article in press
Abstract
The Bcl-2 family is considered the guardian of the mitochondrial apoptotic pathway. We demonstrate that Bim acts as a molecular rheostat by controlling macrophage function not only in lymphoid organs but also in end organs, thereby preventing the break in tolerance. Mice lacking Bim in myeloid cells (LysMCreBimfl/fl) develop a systemic lupus erythematosus (SLE)-like disease that mirrors aged Bim-/- mice, including loss of marginal zone macrophages, splenomegaly, lymphadenopathy, autoantibodies (including anti-DNA IgG), and a type I interferon signature. LysMCreBimfl/fl mice exhibit increased mortality attributed to glomerulonephritis (GN). Moreover, the toll-like receptor signaling adaptor protein TRIF (TIR-domain-containing adapter-inducing interferon-beta) is essential for GN, but not systemic autoimmunity in LysMCreBimfl/fl mice. Bim-deleted kidney macrophages exhibit a novel transcriptional lupus signature that is conserved within the gene expression profiles from whole kidney biopsies of patients with SLE. Collectively, these data suggest that the Bim may be a novel therapeutic target in the treatment of SLE.
Publisher
Rockefeler Uni Press
WEHI Research Division(s)
Molecular Genetics Of Cancer
PubMed ID
29114065
Rights Notice
Refer to copyright notice on published article.


Creation Date: 2017-11-29 08:57:56
Last Modified: 2017-11-29 09:14:19
An error has occurred. This application may no longer respond until reloaded. Reload 🗙